CD4 and AIDS: PML is believed to be developed exclusively in immunosuppressive patients with significantly higher incidence in patients with AIDS, particularly in AIDS patients without cART and with a low CD4+ lymphocyte count, than in patients with any other immunosuppressive conditions.